These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8069184)

  • 21. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are GATA1 mutations occurring at random in Down syndrome transient leukemia?
    Satgé D
    Med Hypotheses; 2014 Aug; 83(2):154-9. PubMed ID: 24880866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transient myeloproliferative disorder (TMD) with transiently increased tetrasomy-21 cells in a phenotypically normal newborn].
    Takeda T; Murano K; Chihara H; Taki M; Watanabe A; Yamada K; Sugita K; Nakazawa S
    Rinsho Ketsueki; 1989 Jul; 30(7):1010-5. PubMed ID: 2810785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell surface phenotyping of megakaryoblasts.
    Koike T; Aoki S; Maruyama S; Narita M; Ishizuka T; Imanaka H; Adachi T; Maeda H; Shibata A
    Blood; 1987 Mar; 69(3):957-60. PubMed ID: 3028539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant.
    Shimizu R; Kobayashi E; Engel JD; Yamamoto M
    Genes Cells; 2009 Sep; 14(9):1119-31. PubMed ID: 19682090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation induction of blast cells in two cases of childhood acute megakaryoblastic leukemia in vitro by interleukin-3 and interleukin-6: an ultrastructural cytochemical study.
    Miyauchi J; Sugita K; Okui M; Taguchi N; Clark SC; Shimizu K
    J Cell Physiol; 1991 Sep; 148(3):404-13. PubMed ID: 1655816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia.
    Vukadin L; Kim JH; Park EY; Stone JK; Ungerleider N; Baddoo MC; Kong HK; Richard A; Tran J; Giannini H; Flemington EK; Lim SS; Ahn EE
    Cancer Gene Ther; 2021 Sep; 28(9):1000-1015. PubMed ID: 33247227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome.
    Brissette MD; Duval-Arnould BJ; Gordon BG; Cotelingam JD
    Am J Hematol; 1994 Dec; 47(4):316-9. PubMed ID: 7977305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.
    Mercher T; Raffel GD; Moore SA; Cornejo MG; Baudry-Bluteau D; Cagnard N; Jesneck JL; Pikman Y; Cullen D; Williams IR; Akashi K; Shigematsu H; Bourquin JP; Giovannini M; Vainchenker W; Levine RL; Lee BH; Bernard OA; Gilliland DG
    J Clin Invest; 2009 Apr; 119(4):852-64. PubMed ID: 19287095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute megakaryoblastic leukemia.
    Gassmann W; Löffler H
    Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of erythroid-specific genes in megakaryoblastic disorders.
    Ito E; Kasai M; Toki T; Arai K; Yokoyama M
    Leuk Lymphoma; 1996 Nov; 23(5-6):545-50. PubMed ID: 9031085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
    Crispino JD
    Pediatr Blood Cancer; 2005 Jan; 44(1):40-4. PubMed ID: 15390312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
    Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
    Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo.
    Takeuchi S; Sugito S; Uemura Y; Miyagi T; Kubonishi I; Taguchi H; Enzan H; Ohtsuki Y; Miyoshi I
    Leukemia; 1992 Jun; 6(6):588-94. PubMed ID: 1602796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood acute megakaryoblastic leukemia with internalization of hemic cells.
    Shimizu H; Ui T; Sasaki K; Kawai S; Kaneko Y; Fujimoto T
    Am J Pediatr Hematol Oncol; 1990; 12(4):477-9. PubMed ID: 2285130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
    Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
    Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural investigation of DNA in megakaryoblastic leukemia by using osmium-ammine-B: comparison with several types of leukemia.
    Ohwada Y; Eguchi M
    Med Oncol Tumor Pharmacother; 1993; 10(3):117-24. PubMed ID: 8264256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloproliferative disorders terminating in acute megakaryoblastic leukemia with chromosome 3q26 abnormality.
    Akahoshi M; Oshimi K; Mizoguchi H; Okada M; Enomoto Y; Watanabe Y
    Cancer; 1987 Dec; 60(11):2654-61. PubMed ID: 3479228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.